Resistomycin attenuates triple-negative breast cancer progression by inhibiting E3 ligase Pellino-1 and inducing SNAIL/SLUG degradation

Signal Transduct Target Ther. 2020 Jul 29;5(1):133. doi: 10.1038/s41392-020-00255-y.

Shan-Shan Liu^#^{1

2}, Jie Qi^#¹, Zu-Dong Teng³, Fu-Tao Tian³, Xiao-Xi Lv², Ke Li⁴, Ya-Jie Song¹, Wei-Dong Xie², Zhuo-Wei Hu⁵, Xia Li⁶

¹ Department of Pharmacy, Marine College, Shandong University, Weihai, 264209, China.
² Molecular Immunology and Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
³ Department of Pathology, Changle People's Hospital, Weifang, 262499, China.
⁴ Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
⁵ Molecular Immunology and Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China. huzhuowei@imm.ac.cn.
⁶ Department of Pharmacy, Marine College, Shandong University, Weihai, 264209, China. xiali@sdu.edu.cn.

^# Contributed equally.

No abstract available

Publication types